ORIGINAL ARTICLE


Acesso aberto Revisado por pares

0

Visualização

The future of precision medicine in opioid use disorder: inclusion of patient-important outcomes in clinical trials

Nitika Sanger1*, Balpreet Panesar2*, Tea Rosic3, Brittany Dennis4, Alessia D&rsquo,Elia2, Alannah Hillmer2, Caroul Chawar2, Leen Naji5, Jacqueline Hudson3, M. Constantine Samaan6,7,8, Russell J. de Souza7,9, David C. Marsh10, Lehana Thabane7, Zainab Samaan3,7,9,11

DOI: 10.1590/1516-4446-2019-0734

Epub: 12 de Junho de 2020

Vol.43 Issue 2/2021:

1Medical Science Graduate Program, McMaster University, Hamilton, ON, Canada
2Neuroscience Graduate Program, McMaster University, Hamilton, ON, Canada
3Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada
4Department of Medicine, McMaster University, Hamilton, ON, Canada
5Department of Family Medicine, Halton Healthcare, Milton, ON, Canada
6Department of Pediatrics, McMaster University, Hamilton, ON, Canada
7Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada
8Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada
9Population Genomics Program, Chanchlani Research Centre, McMaster University, Hamilton, ON, Canada
10Northern Ontario School of Medicine, Laurentian University, Sudbury, ON, Canada
11Clinician Investigator Program, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada

Corresponding author

Zainab Samaan, Clinician Investigator Program, Faculty of Health Sciences, McMaster University, 100 West 5th St., Hamilton, ON, L8N 3K7, Canada. E-mail: samaanz@mcmaster.ca


© 2026 All rights reserved